Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
BlackRock MuniHoldings Fund
MHD
$600M
| $11M | ﹤0.01% |
936,680
+169,188
| +22% | +$1.98M |
|
3502
SFL Corp
SFL
$1.61B
| $11M | ﹤0.01% |
1,407,394
+239,993
| +21% | +$1.84M |
|
3503
VictoryShares Dividend Accelerator ETF
VSDA
$250M
| $11M | ﹤0.01% |
207,870
+436
| +0.2% | +$23K |
|
3504
Employers Holdings
EIG
$912M
| $11M | ﹤0.01% |
253,954
+12,382
| +5% | +$505K |
|
3505
Invesco Biotechnology & Genome ETF
PBE
$288M
| $11M | ﹤0.01% |
133,303
+35,317
| +36% | +$2.73M |
|
3506
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$350M
| $10.9M | ﹤0.01% |
162,016
-173
| -0.1% | -$11.7K |
|
3507
iShares MSCI Singapore ETF
EWS
$1.03B
| $10.9M | ﹤0.01% |
397,294
-44,211
| -10% | -$1.24M |
|
3508
First Merchants
FRME
$2.7B
| $10.9M | ﹤0.01% |
291,208
+9,035
| +3% | +$335K |
|
|
BSCY
3509
Invesco BulletShares 2034 Corporate Bond ETF
BSCY
$553M
| $10.9M | ﹤0.01% |
518,972
+64,582
| +14% | +$1.36M |
|
|
VRE
3510
DELISTED
Veris Residential
VRE
| $10.9M | ﹤0.01% |
732,380
+34,413
| +5% | +$508K |
|
3511
Global X SuperDividend US ETF
DIV
$796M
| $10.8M | ﹤0.01% |
625,642
-28,571
| -4% | -$497K |
|
3512
Grindr
GRND
$2.95B
| $10.8M | ﹤0.01% |
798,403
-357,518
| -31% | -$4.86M |
|
|
TE.WS
3513
DELISTED
T1 Energy Inc Warrants
TE.WS
| $10.8M | ﹤0.01% |
9,236,836
| – | – |
|
|
CET
3514
Central Securities Corp
CET
$1.56B
| $10.8M | ﹤0.01% |
212,816
+19,445
| +10% | +$984K |
|
3515
First Trust California Municipal High income ETF
FCAL
$220M
| $10.8M | ﹤0.01% |
218,423
+8,879
| +4% | +$437K |
|
|
MESO
3516
Mesoblast
MESO
$1.87B
| $10.8M | ﹤0.01% |
596,952
+131,151
| +28% | +$2.26M |
|
3517
MarineMax
HZO
$782M
| $10.8M | ﹤0.01% |
444,263
+232,904
| +110% | +$5.75M |
|
3518
Astrana Health
ASTH
$1.88B
| $10.8M | ﹤0.01% |
433,825
-64,042
| -13% | -$1.7M |
|
|
SAFE
3519
Safehold
SAFE
$1.19B
| $10.7M | ﹤0.01% |
783,767
-144,136
| -16% | -$2.05M |
|
|
MAZE
3520
Maze Therapeutics
MAZE
$1.54B
| $10.7M | ﹤0.01% |
258,086
+45,324
| +21% | +$1.56M |
|
|
EFR
3521
Eaton Vance Senior Floating-Rate Fund
EFR
$312M
| $10.7M | ﹤0.01% |
958,312
-84,953
| -8% | -$952K |
|
3522
Ocular Therapeutix
OCUL
$1.85B
| $10.7M | ﹤0.01% |
879,144
-1,586,532
| -64% | -$19.3M |
|
|
CHY
3523
Calamos Convertible and High Income Fund
CHY
$1B
| $10.7M | ﹤0.01% |
943,356
+15,885
| +2% | +$182K |
|
3524
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.45B
| $10.6M | ﹤0.01% |
216,362
+44,071
| +26% | +$2.19M |
|
|
HELP
3525
Cybin Inc
HELP
$471M
| $10.6M | ﹤0.01% |
1,299,756
+1,072,095
| +471% | +$6.9M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.